Murugappan · Journal of assisted reproduction and genetics 2025 · retrospective cohort study · n=2270

Clinical utilization and outcomes over eight consecutive years following oocyte cryopreservation.

Cited 1 times in the scientific literature.

Level 3 - non-randomized controlled study

Retrospective comparative cohort study

PubMed 39633145 · doi:10.1007/s10815-024-03334-z · record verified 2026-08-26

What was done

This retrospective cohort study compared embryologic and clinical outcomes between oocyte cryopreservation (OC) and immediate fertilization for embryo cryopreservation (EC) in non-infertile women aged 18 to 42 treated at a single fertility center between 2016 and 2023. All cycles used intracytoplasmic sperm injection (ICSI), preimplantation genetic testing for aneuploidy (PGT-A), and elective single-embryo transfer (eSET). Outcomes were compared between 3,697 thawed metaphase II (MII) oocytes from 239 OC patients and 28,959 fresh MII oocytes from 2,031 EC patients.

What was found

Thawed MII oocyte survival averaged 92% across age groups. Thawed oocytes had a significantly lower fertilization rate than fresh oocytes (85% vs 90%, p < 0.05). The mean number of MII oocytes required per blastocyst was significantly higher for thawed versus fresh oocytes across all age brackets (p < 0.05): 2.9 vs 2.2 (ages 18–34), 3.3 vs 2.5 (ages 34–37), 3.9 vs 2.9 (ages 38–40), and 7.5 vs 3.9 (ages 41–42). Among patients who reached euploid embryo transfer, clinical pregnancy rates (p = 0.82) and live birth rates (p = 0.79) per transfer were similar (exact percentages not reported in abstract).

Why it matters

These findings provide age-stratified benchmarks for oocyte-to-blastocyst efficiency, helping clinicians provide realistic counseling to women freezing eggs regarding how many oocytes they may need depending on age.

Limits

The study is retrospective and conducted at a single fertility clinic, which may limit generalizability across different laboratory protocols. The OC cohort was substantially smaller than the EC cohort (239 vs 2,031 patients). The abstract does not provide exact percentages for clinical pregnancy or live birth rates, nor long-term neonatal outcomes.

Cited by